Mesa Laboratories, Inc. Share Price
NASDAQ: MLAB | Small CapMesa Laboratories, Inc. Stock Performance
Open $109.94 | Prev. Close $110.98 | Circuit Range N/A |
Day Range $109.63 - $112.43 | Year Range $59.58 - $112.43 | Volume 14,145 |
Average Traded $110.77 |
Mesa Laboratories, Inc. Share Price Today
As of 14 August 2026, Mesa Laboratories, Inc.'s share price is $113.17. The stock opened at $109.94, compared to its previous close of $110.98. During today's trading session, Mesa Laboratories, Inc.'s share price traded between $109.63 and $112.43, with an average price of $111.03. Over the past 52 weeks, the stock has recorded a high of $112.43 and a low of $59.58. In terms of performance, Mesa Laboratories, Inc.'s share price has risen by 18.24% over the last six months and is up 67.04% on a year-on-year basis.
Mesa Laboratories, Inc. Share Price Chart
Mesa Laboratories, Inc. Stock Fundamentals & Key Indicators
Market Cap $613.49M | PE Ratio (TTM) -314.36 | Dividend Yield 0.57% |
EPS (TTM) $-0.36 | Revenue (TTM) $240.98M | Return On Equity (TTM) -1.24% |
Profit Margin -0.82% | Debt to Equity 1.03 | Quarterly Earnings Growth YoY 316.59% |
Mesa Laboratories, Inc. Quarterly Profit & Loss
All figures in USD
Mesa Laboratories, Inc. Annual Profit & Loss
All figures in USD
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $104.82 | $112.43 | +11.44% |
Jul 2026 | $101.29 | $100.89 | +1.61% |
Jun 2026 | $101.70 | $99.29 | -2.24% |
May 2026 | $98.08 | $101.57 | +1.27% |
Apr 2026 | $89.91 | $100.30 | +13.86% |
Mar 2026 | $94.78 | $88.09 | -7.96% |
Feb 2026 | $79.45 | $95.71 | +21.04% |
Jan 2026 | $79.25 | $79.08 | +1.35% |
Dec 2025 | $79.47 | $78.02 | -2.28% |
Nov 2025 | $72.38 | $79.84 | +10.87% |
Oct 2025 | $68.09 | $72.01 | +7.59% |
Sep 2025 | $66.11 | $66.93 | -1.21% |